Hot-Topics

Rapid detection of prostate cancer with a saliva test.

Men's prostate cancer is the most frequent cancer in Germany, and it's likely to stay that way. Researchers forecast a doubling of cases globally within the next two decades. A novel saliva test aims to identify potential illnesses more swiftly and accurately.

SymClub
Jun 1, 2024
2 min read
NewsProstate cancerMedicineColorectal cancerBreast cancerCancer
Prostate cancer could also be detected more quickly with a palpation examination
Prostate cancer could also be detected more quickly with a palpation examination

Attention!

Limited offer

Learn more

The illness has yet to emerge. - Rapid detection of prostate cancer with a saliva test.

Stunned by Prostate Cancer, individuals mostly fall between the ages of 55 and 69. With the rising population, there's an increasing likelihood of more occurrences.

Recently, "The Guardian" Britain announced: A groundbreaking new test can now extract a DNA sample in a matter of seconds, effectively determining who's really at risk of prostate cancer. Originated by scientists at the "Institute of Cancer Research, London" (ICR) and the "Royal Marsden NHS Foundation Trust".

In the past, blood tests were often criticized for delivering false-positive outcomes. In a study, it was discovered that two out of every three tests failed to recognize the cancer risk.

Ros Eeles, Professor of Oncogenetics at ICR, shares, "We've proven that a basic saliva test can pinpoint men with a genetic predisposition, enabling early detection of the disease." Her team's efforts mark the culmination of decades of research on the genetic markers of prostate cancer.

How DNA from saliva forms a trustworthy source of data

The research team analyzed the DNA of countless men, looking for genetic signals in saliva that point towards prostate cancer. Next, they took saliva samples from 6,000 European men aged 55 to 69 with an increased risk of prostate cancer gathered from medical offices.

Findings of the study

Men at the highest genetic risk saw fewer false-positive outcomes from this test than the traditional PSA blood test, according to the scientists. It primarily identified those with cancer whom the PSA test would have missed, and discovered a greater proportion of aggressive cancer types than the PSA test.

Moreover, this test identified men with prostate cancer who had been overlooked by an MRI examination.

Despite its promising results, Eeles cautions, "Further research work still needs to be done before the saliva test can be implemented into doctors' practices." Their plans include testing the genetic markers associated with prostate cancer risk in various population groups to ensure it's advantageous for all men.

Read also:

Attention!

Limited offer

Learn more